Literature DB >> 17962772

Synthesis and analgesic activity evaluation of some agmatine derivatives.

Hongxia He1, Mengjia Liu, Zhibing Zheng, Ying Liu, Junhai Xiao, Ruibin Su, Chun Hu, Jin Li, Song Li.   

Abstract

A series of N,N'-disubstituted-2-nitroethene-1,1-diamine and N,N'-disubstituted- N''-cyanoguanidine derivatives were prepared and evaluated for in vivo analgesic activity. The blood brain barrier (BBB) VolSurf model was used to predict the BBB permeation profiles of our synthesized compounds. Some compounds show both remarkable analgesic activity and good BBB permeation profiles, and these compounds might be developed for treatment of opioid tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17962772      PMCID: PMC6148528          DOI: 10.3390/11060393

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  17 in total

1.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds.

Authors:  G Cruciani; M Pastor; W Guba
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

Review 2.  A simple model to predict blood-brain barrier permeation from 3D molecular fields.

Authors:  Frédéric Ooms; Peter Weber; Pierre Alain Carrupt; Bernard Testa
Journal:  Biochim Biophys Acta       Date:  2002-07-18

3.  Effects of agmatine on tolerance to and substance dependence on morphine in mice.

Authors:  J Li; X Li; G Pei; B Y Qin
Journal:  Zhongguo Yao Li Xue Bao       Date:  1999-03

4.  Modulation of opioid analgesia by agmatine.

Authors:  Y Kolesnikov; S Jain; G W Pasternak
Journal:  Eur J Pharmacol       Date:  1996-01-18       Impact factor: 4.432

5.  Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs.

Authors:  José L Falcó; Maia Lloveras; Irma Buira; Jordi Teixidó; José I Borrell; Eva Méndez; José Terencio; Albert Palomer; Antonio Guglietta
Journal:  Eur J Med Chem       Date:  2005-08-10       Impact factor: 6.514

6.  Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats.

Authors:  J Li; X Li; G Pei; B Y Qin
Journal:  Zhongguo Yao Li Xue Bao       Date:  1999-01

7.  Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

Authors:  B Masereel; J Wouters; L Pochet; D Lambert
Journal:  J Med Chem       Date:  1998-08-13       Impact factor: 7.446

Review 8.  A biphasic opioid function modulator: agmatine.

Authors:  Rui-Bin Su; Jin Li; Bo-Yi Qin
Journal:  Acta Pharmacol Sin       Date:  2003-07       Impact factor: 6.150

9.  Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.

Authors:  Arturo Perez-Medrano; Steven A Buckner; Michael J Coghlan; Robert J Gregg; Murali Gopalakrishnan; Michael E Kort; John K Lynch; Victoria E Scott; James P Sullivan; Kristi L Whiteaker; William A Carroll
Journal:  Bioorg Med Chem Lett       Date:  2004-01-19       Impact factor: 2.823

10.  Agmatine: an endogenous clonidine-displacing substance in the brain.

Authors:  G Li; S Regunathan; C J Barrow; J Eshraghi; R Cooper; D J Reis
Journal:  Science       Date:  1994-02-18       Impact factor: 47.728

View more
  4 in total

1.  Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage.

Authors:  John E Piletz; Stephanie Klenotich; Ken S Lee; Qian Long Zhu; Edward Valente; Michael A Collins; Vyvyca Jones; Soeb Nam Lee; Feng Yangzheng
Journal:  Neurotox Res       Date:  2013-01-19       Impact factor: 3.911

2.  Endogenous Agmatine Induced by Ischemic Preconditioning Regulates Ischemic Tolerance Following Cerebral Ischemia.

Authors:  Jae Hwan Kim; Jae Young Kim; Jin Young Jung; Yong Woo Lee; Won Taek Lee; Seung Kon Huh; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2017-12-13       Impact factor: 3.261

3.  Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation.

Authors:  William K Taverner; Egon J Jacobus; John Christianson; Brian Champion; Adrienne W Paton; James C Paton; Weiheng Su; Ryan Cawood; Len W Seymour; Janet Lei-Rossmann
Journal:  Mol Ther Oncolytics       Date:  2019-09-28       Impact factor: 7.200

4.  High-level production of the agmatine in engineered Corynebacterium crenatum with the inhibition-releasing arginine decarboxylase.

Authors:  Fengyu Yang; Jiayu Xu; Yichun Zhu; Yi Wang; Meijuan Xu; Zhiming Rao
Journal:  Microb Cell Fact       Date:  2022-01-31       Impact factor: 5.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.